Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 18.26 SEK -4.85% Market Closed
Market Cap: 852.6m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Relative Value

The Relative Value of one MOB stock under the Base Case scenario is 0.61 SEK. Compared to the current market price of 18.26 SEK, Moberg Pharma AB (publ) is Overvalued by 97%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MOB Relative Value
Base Case
0.61 SEK
Overvaluation 97%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
0
Median 3Y
110.8
Median 5Y
31.1
Industry
2.5
Forward
92.1
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-11.2
Industry
21.9
Forward
-35.5
vs History
vs Industry
Median 3Y
-18.4
Median 5Y
-26.5
Industry
16.5
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-17
Industry
23.6
vs History
69
vs Industry
26
Median 3Y
0.9
Median 5Y
2.3
Industry
2.1
vs History
33
vs Industry
0
Median 3Y
24.1
Median 5Y
29.9
Industry
2.6
Forward
56.5
vs History
28
vs Industry
0
Median 3Y
0
Median 5Y
27.7
Industry
5.2
vs History
vs Industry
52
Median 3Y
-19.6
Median 5Y
-19.6
Industry
13.3
Forward
-24.2
vs History
vs Industry
49
Median 3Y
-18.6
Median 5Y
-18.6
Industry
16.6
Forward
-18.8
vs History
vs Industry
51
Median 3Y
-16.6
Median 5Y
-21.8
Industry
15.6
vs History
vs Industry
38
Median 3Y
-16.6
Median 5Y
-21.8
Industry
19.1
vs History
71
vs Industry
27
Median 3Y
0.9
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

MOB Competitors Multiples
Moberg Pharma AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Moberg Pharma AB (publ)
STO:MOB
836.9m SEK 169.8 -36.8 -18.8 -17.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
SE
Moberg Pharma AB (publ)
STO:MOB
Average P/E: 32.4
Negative Multiple: -36.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top